Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB25FNMWQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,245
Award facts
- Contract value 100% obligated
- $17,245.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $17,245.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). This delivery order, issued September 3, 2025, with an ultimate completion date of September 4, 2025, carries no set-aside designation. DMS Pharmaceutical Group will perform the work at its Park Ridge facility and deliver the oncology medication to support military healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a comprehensive pharmaceutical supply vehicle valued at $499,999,999 and valid through November 2026. As a woman-owned small business, DMS Pharmaceutical Group has established itself as a critical pharmaceutical supplier to Department of Defense healthcare facilities nationwide, providing an extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables. The company's track record of successful federal pharmaceutical contract awards demonstrates its capability to reliably support military medical supply requirements across various product categories and therapeutic areas.
Quick answers
Who was awarded contract SPE2DB25FNMWQ?
SPE2DB25FNMWQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FNMWQ worth?
The government has obligated $17,245 on SPE2DB25FNMWQ.
Is contract SPE2DB25FNMWQ an order under another contract?
Yes. SPE2DB25FNMWQ is a delivery order under SPE2DB25D9348, an indefinite delivery contract.
Was contract SPE2DB25FNMWQ competed?
The extent of competition for SPE2DB25FNMWQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award